Your browser doesn't support javascript.
loading
Improving CRISPR-Cas9 directed faithful transgene integration outcomes by reducing unwanted random DNA integration.
Hermantara, Rio; Richmond, Laura; Taqi, Aqeel Faisal; Chilaka, Sabari; Jeantet, Valentine; Guerrini, Ileana; West, Katherine; West, Adam.
Affiliation
  • Hermantara R; School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. rio.hermantara@i3l.ac.id.
  • Richmond L; Department of Biomedicine, School of Life Sciences, Indonesia International Institute for Life Sciences, Jakarta, Indonesia. rio.hermantara@i3l.ac.id.
  • Taqi AF; School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Chilaka S; School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Jeantet V; School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Guerrini I; School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • West K; School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • West A; School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
J Biomed Sci ; 31(1): 32, 2024 Mar 26.
Article in En | MEDLINE | ID: mdl-38532479
ABSTRACT

BACKGROUND:

The field of genome editing has been revolutionized by the development of an easily programmable editing tool, the CRISPR-Cas9. Despite its promise, off-target activity of Cas9 posed a great disadvantage for genome editing purposes by causing DNA double strand breaks at off-target locations and causing unwanted editing outcomes. Furthermore, for gene integration applications, which introduce transgene sequences, integration of transgenes to off-target sites could be harmful, hard to detect, and reduce faithful genome editing efficiency.

METHOD:

Here we report the development of a multicolour fluorescence assay for studying CRISPR-Cas9-directed gene integration at an endogenous locus in human cell lines. We examine genetic integration of reporter genes in transiently transfected cells as well as puromycin-selected stable cell lines to determine the fidelity of multiple CRISPR-Cas9 strategies.

RESULT:

We found that there is a high occurrence of unwanted DNA integration which tarnished faithful knock-in efficiency. Integration outcomes are influenced by the type of DNA DSBs, donor design, the use of enhanced specificity Cas9 variants, with S-phase regulated Cas9 activity. Moreover, restricting Cas9 expression with a self-cleaving system greatly improves knock-in outcomes by substantially reducing the percentage of cells with unwanted DNA integration.

CONCLUSION:

Our results highlight the need for a more stringent assessment of CRISPR-Cas9-mediated knock-in outcomes, and the importance of careful strategy design to maximise efficient and faithful transgene integration.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Limits: Humans Language: En Journal: J Biomed Sci Journal subject: MEDICINA Year: 2024 Type: Article Affiliation country: United kingdom

Full text: 1 Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Limits: Humans Language: En Journal: J Biomed Sci Journal subject: MEDICINA Year: 2024 Type: Article Affiliation country: United kingdom